Angelo Guglielmi

Angelo Guglielmi

Auto-generated profile, based on publicly available information

Angelo Guglielmi

Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia , Corso Strada Nuova, 65 - 27100 - Pavia, Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2022 in Blood Purification
Verified
Journal Article
Closed access
PDF file
FFFiorenza Ferrari
Fiorenza Ferrari
FHFaeq Husain-Syed
Faeq Husain-Syed
PMPaola Milla
Paola Milla
ALAnna Lorenzin
Anna Lorenzin
LSLuigia Scudeller
Luigia Scudeller
CRClaudio Ronco
Claudio Ronco
Introduction: At the time of renal replacement therapy, approximately 20% of critically ill patients have septic shock. In this study, medium cutoff (MCO) continuous venovenous hemodialysis (CVVHD) was compared to high-flux membrane continuous venovenous hemodiafiltration (CVVHDF) in terms of hemodynamic improvement, efficiency, middle molecule removal, and inflammatory system activation. Methods: This is a monocenter crossover randomized study. Between December 31, 2017, and December 31, 2019, 20 patients with septic shock and stage 3 acute kidney injury (AKI) admitted to 2 Italian ICUs were enrolled. All patients underwent CVVHD with Ultraflux® EMiC®2 and CVVHDF with AV1000S® without washout. Each treatment lasted 24 h. Results: Compared to AV1000S®-CVVHDF, EMIC®2-CVVHD normalized cardiac index (β = −0.64; p = 0.02) and heart rate (β = 5.72; p = 0.01). Interleukin-8 and myeloperoxidase removal were greater with AV1000S®-CVVHDF than with EMiC®2-CVVHD (β = 0.35; p < 0.001; β = 0.43; p = 0.03, respectively). Leukocytosis improved over 24 h in EMiC®2-CVVHD-treated patients (β = 4.13; p = 0.03), whereas procalcitonin levels decreased regardless of the modality (β = 0.89; p = 0.01) over a 48-h treatment period. Reduction rates, instantaneous plasmatic clearance of urea, creatinine, and β2-microglobulin were similar across modalities. β2-Microglobulin removal efficacy was greater in the EMiC®2 group (β = 0–2.88; p = 0.002), while albumin levels did not differ. Albumin was undetectable in the effluent in both treatments. Discussion: In patients with septic shock and severe AKI, the efficacy of uremic toxin removal was comparable between MCO-CVVHD and CVVHDF. Further, MCO-CVVHD was associated with improved hemodynamics. Fraction of filtration and transmembrane pressure reduction and the maintenance of equal efficacy might be the key features of CVVHD with MCO membranes in critically ill patients.

2 July 2021 in Phlebology: The Journal of Venous Disease
Verified
Journal Article
Closed access
PDF file
ABAntonio Bozzani
Antonio Bozzani
VAVittorio Arici
Vittorio Arici
GTGuido Tavazzi
Guido Tavazzi
SBStefano Boschini
Stefano Boschini
AGAngelo Guglielmi
Angelo Guglielmi
ASAntonio V Sterpetti
Antonio V Sterpetti
Objective: The aim of our study was to analyze the specificity, accuracy and sensitivity of a simple, easy to calculate, prognostic score for hospitalized COVID19 patients developing deep vein thrombosis. Methods: From March 1st to April 28th, 942 COVID-19 patients with severe symptoms were admitted to the hospital San Matteo of Pavia-Italy. Thirty two patients (3.4%) developed deep vein thrombosis during hospitalization. In all patients hemostatic and inflammatory parameters were abnormal. A simple prognostic score was developed based on the presence of specific co morbidities and D-dimers levels (quick San Matthew Score-quick SMS): Results: Nine patients died in a condition of multiple organ failure, 23 patients (71.9%) survived and left the hospital in good general conditions. The developed score was based simply on two parameters: 1) presence of four specific co morbidities and 2)systemic levels of D-Dimers. The quick San Matthew Score resulted in a sensitivity, specificity and overall accuracy of more than 90% (94%, 92%,93% respectively) and compared favorably with other scores. The score was prospectively validated in 100 COVID19 patients who developed deep vein thrombosis collected from the literature and prospectively confirmed in our hospital. Conclusions: The findings of our study underline the importance of an immediate aggressive therapeutic approach for moderate and high-risk patients with COVID19 infection. The quick SMS score may help to identify patients at high risk for mortality and to follow the clinical outcome of the patient. A simple, easy to calculate prognostic score may also facilitate communication among health workers.

14 March 2022 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
CCCostanza Natalia Julia Colombo
Costanza Natalia Julia Colombo
AGAngelo Guglielmi
Angelo Guglielmi
FMFrancesco Mojoli
Francesco Mojoli
GTGuido Tavazzi
Guido Tavazzi
A 65-year-old lady was admitted due to cardiogenic shock related to acute decompensated heart failure refractory to medical therapy, requiring oro-tracheal tube and intra-aortic balloon pump (IABP) placement. In addition to echocardiography, transorbital transcranial colour Doppler (TCOD) was performed to assess cerebral flow pattern at different steps of IABP support; the figure shows TCOD and echocardiographic images, respectively in the upper and lower panel, during these different phases: IABP 1:1, first step (Panel A), IABP 1:2, second step (Panel B), and IABP switched off, third step (Panel C).